India Readies 5 Sites For Phase 3 Human Trials Of Oxford Covid-19 Vaccine; SII To Start Manufacturing Next Month

<strong>New Delhi: </strong>In a recent development regarding the Oxford Vaccine phase 3 trials, Renu Swarup,  Secretary of Department of Biotechnology (DBT) confirmed that Five sites across the country are ready for the third and final phase of human trials of the Oxford-AstraZeneca COVID-19 vaccine. ALSO READ|<a href="https://news.abplive.com/news/world/coronavirus-cure-covid-19-treatment-vaccine-good-news-in-2-weeks-says-trump-1297078"><span style="color: #ff0000;">Coronavirus: 'Good News